Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
144.00    -1.00 (-0.69%)
Bid:
144.00
Ask:
145.00
Spread: 1.00 (0.694%)
Market Cap: £113.00m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

Trading Statement-COVID-19 & Preliminary Statement

23 Mar 2020 17:47

RNS Number : 2844H
Xaar PLC
23 March 2020
 

Xaar plc

 

Trading update and revised date for full year results 

 

Xaar plc ("Xaar" or the "Group"), the leading inkjet printing technology Group, announces a confirmation of previous guidance and a revised date for the presentation of full year results.

 

Full year results

 

Preliminary financial statements for the 12 months ended 31 December 2019 were scheduled to be released 24 March 2020.

 

The FCA has strongly requested all listed companies observe a moratorium on the publication of preliminary financial statements for at least two weeks.

 

In compliance with this request, Xaar will not be releasing preliminary financial statements, but will publish full audited financial statements within four months of the financial year end, subject to any further guidance from the FCA.

 

Trading update

 

Xaar continues to make good progress with its strategy and re-iterates the preliminary guidance for 2019:

 

The Group expects to report revenues for its continuing operations of £49.4 million for the year ended 31 December 2019.

 

Group cash balances (including cash held for investment in Xaar 3D) were £25.3 million at 31 December 2019.

 

COVID19 - Update

 

The health, safety and security of our employees is our upmost priority and appropriate actions have been taken to our operational procedures to mitigate risk.

 

The Group's trading performance in 2020 to date has been in line with expectations. No orders have been cancelled, however we are mindful of the rapidly changing environment in which the business is operating.

 

While the full implications of COVID-19 on the financial performance for the current financial year are difficult to determine at this stage, the Board remains confident in the long-term prospects of the Group.

 

 

Enquiries:

Xaar plc

+44 (0)1223 423 663 

John Mills, Chief Executive Officer

Ian Tichias, Chief Finance Officer

 

 

Tulchan Communications

+44 (0)20 7353 4200

James Macey White

Giles Kernick

Hollie Ralston

 

About XaarXaar is a world leader in the development of digital inkjet technology. Our technology drives the conversion of analogue printing and manufacturing methods to digital inkjet which is more efficient, more economical and more productive than the traditional methods which have been in use for years. We design and manufacture printheads as well as systems for product decoration and industrial 3D Printing which use our inkjet technology. We are the only truly independent inkjet technology company with over 25 years of know how. We offer unrivalled inkjet expertise including technology and printhead design and development and manufacture highly customised product decoration systems and industrial 3D Printing for volume manufacturing. Our unique technologies and products are the leading enabler for innovation and for driving supply chain efficiencies for many industries. Information about Xaar is at www.xaar.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTPPUQCWUPUGMW
Date   Source Headline
8th Dec 20069:43 amRNSRule 2.10 Announcement
7th Dec 20067:01 amRNSTrading Update for FY 2006
6th Dec 20061:08 pmRNSEPT Disclosure
4th Dec 20064:14 pmRNSEPT Disclosure-Amendment
4th Dec 20063:43 pmRNSHolding(s) in Company
4th Dec 200611:30 amRNSEPT Disclosure
1st Dec 20066:48 pmRNSEPT Disclosure-Amendment
1st Dec 200612:12 pmRNSEPT Disclosure
30th Nov 200612:20 pmRNSEPT Disclosure
29th Nov 200612:13 pmRNSEPT Disclosure
27th Nov 200612:34 pmRNSEPT Disclosure
23rd Nov 20069:18 amRNSRule 2.10 Announcement
21st Nov 20062:49 pmRNSRule 8.3- Xaar PLC
21st Nov 200612:35 pmRNSEPT Disclosure
21st Nov 20069:14 amRNSHolding(s) in Company
20th Nov 200612:18 pmRNSEPT Disclosure
17th Nov 200612:17 pmRNSEPT Disclosure
17th Nov 20067:00 amRNSHolding(s) in Company
16th Nov 200612:24 pmRNSEPT Disclosure
14th Nov 20064:39 pmRNSStatement re Xaar plc
14th Nov 20062:58 pmRNSStatement re Possible Offer
9th Nov 20064:39 pmRNSHolding(s) in Company
1st Nov 20067:00 amRNSHolding(s) in Company
26th Oct 20067:00 amRNSHolding(s) in Company
25th Sep 20066:06 pmRNSHolding(s) in Company
18th Sep 20067:00 amRNSHolding(s) in Company
15th Sep 20066:29 pmRNSHolding(s) in Company
13th Sep 20067:01 amRNSInterim Results
31st Aug 20061:40 pmRNSHolding(s) in Company
30th Aug 20062:00 pmRNSNotice of Interim Results
21st Aug 20063:09 pmRNSHolding(s) in Company
11th Aug 20068:39 amRNSHolding(s) in Company
9th Aug 20067:00 amRNSTrading Update
17th Jul 20066:31 pmRNSHolding(s) in Company
17th Jul 20066:25 pmRNSHolding(s) in Company
14th Jul 20066:25 pmRNSHolding(s) in Company
4th Jul 20065:35 pmRNSHolding(s) in Company
3rd Jul 20067:00 amRNSHolding(s) in Company
30th Jun 20066:28 pmRNSHolding(s) in Company
13th Jun 20067:00 amRNSHolding(s) in Company
13th Jun 20067:00 amRNSHolding(s) in Company
19th May 20066:16 pmRNSHolding(s) in Company
19th May 20066:03 pmRNSHolding(s) in Company
19th May 20065:58 pmRNSHolding(s) in Company
19th May 20065:50 pmRNSHolding(s) in Company
19th May 20063:53 pmRNSDirector/PDMR Shareholding
16th May 20066:32 pmRNSDirector/PDMR Shareholding
15th May 20063:17 pmRNSHolding(s) in Company
12th May 20065:30 pmRNSDirector/PDMR Shareholding
12th May 20067:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.